CH647945A5 - Lyophilised, enzymatically degraded sour milk product - Google Patents

Lyophilised, enzymatically degraded sour milk product Download PDF

Info

Publication number
CH647945A5
CH647945A5 CH12468/78A CH1246878A CH647945A5 CH 647945 A5 CH647945 A5 CH 647945A5 CH 12468/78 A CH12468/78 A CH 12468/78A CH 1246878 A CH1246878 A CH 1246878A CH 647945 A5 CH647945 A5 CH 647945A5
Authority
CH
Switzerland
Prior art keywords
sour milk
product
milk
amino acids
free amino
Prior art date
Application number
CH12468/78A
Other languages
German (de)
Inventor
Maria Baltadjieva
Nikola Nikolov
Maria Angelakova
Todor Vitanov
Peter Fridmanov
Margarita Vassileva
Zvetan Zvetkov
Tota Paunkova
Rumjana Kumanova
Vassilka Valtschanova
Original Assignee
Dso Pharmachim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dso Pharmachim filed Critical Dso Pharmachim
Publication of CH647945A5 publication Critical patent/CH647945A5/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A23C9/1209Proteolytic or milk coagulating enzymes, e.g. trypsine
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1232Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt in powdered, granulated or dried solid form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986Milk; Derivatives thereof, e.g. butter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Description

647 945 647 945

2 2

Claims (2)

PATENTANSPRÜCHEPATENT CLAIMS 1. Lyophilisiertes, enzymatisch abgebautes Sauermilchprodukt, bestimmt für kosmetische und pharmazeutische Zwecke, das folgende Zusammensetzung aufweist: 15,5 bis 16,5% freie Aminosäuren, 5 bis 11% Wasser, 45 bis 50% Laktose, 27 bis 33% gesamtes Eiweiss, 25 bis 28% lösliches Eiweiss, 1,4 bis 2% Peptonstickstoff, 7 bis 8% Asche, einen Säuregrad von 130° bis 150° TH, einen pH-Wert von 3,8 bis 4,1 und aktive Lactobacillus bulgaricum-Zellen von mehr als 100 000 pro g Sauermilchprodukt.1. Lyophilized, enzymatically degraded sour milk product intended for cosmetic and pharmaceutical purposes, which has the following composition: 15.5 to 16.5% free amino acids, 5 to 11% water, 45 to 50% lactose, 27 to 33% total protein, 25 to 28% soluble protein, 1.4 to 2% peptone nitrogen, 7 to 8% ash, an acidity of 130° to 150° TH, a pH of 3.8 to 4.1 and active Lactobacillus bulgaricum cells from more than 100 000 per g of sour milk product. 2. Verfahren zur Herstellung eines Sauermilchproduktes gemäss Anspruch 1, dadurch gekennzeichnet, dass entfettete, pasteurisierte und bis zu 45 °C abgekühlte Milch mit 0,1 bis 0,3% Pankreatin vermischt und nach 30 Minuten mit 1 bis 3% einer bakteriellen Kombination aus Streptococcus thermophilus Stamm 2 ST BTCC Nr. 113 und Lactobacillus bul-garicum Stamm 5 SB BTCC Nr. 114 beimpft wird, wonach sie drei Stunden lang bei 44-46 °C fermentiert wird, anschliessend 0,1 bis 0,3% Pepsin zugegeben werden, und man das so erhaltene Produkt bei 20-25 °C 24 Stunden lang aufbewahrt und danach lyophilisiert.2. Process for the production of a sour milk product according to claim 1, characterized in that defatted, pasteurized and up to 45 °C cooled milk is mixed with 0.1 to 0.3% pancreatin and after 30 minutes with 1 to 3% of a bacterial combination Streptococcus thermophilus strain 2 ST BTCC No. 113 and Lactobacillus bul-garicum strain 5 SB BTCC No. 114, after which it is fermented at 44-46°C for three hours, followed by the addition of 0.1 to 0.3% pepsin , and the product thus obtained is stored at 20-25 °C for 24 hours and then lyophilized. Die Erfindung betrifft ein lyophilisiertes enzymatisch abgebautes Sauermilchprodukt, das für kosmetische und pharmazeutische Zwecke bestimmt ist sowie ein Verfahren zu dessen Herstellung.The invention relates to a lyophilized, enzymatically degraded sour milk product intended for cosmetic and pharmaceutical purposes and to a process for its production. Joghurt ist eine Abart von Sauermilch und stellt ein Produkt dar, welches durch seine Nähr- und bioaktiven Eigenschaften bekannt ist, was auf seine sich bei den Fermentationsprozessen bildenden Komponenten und auf die zufolge der Lebensaktivität des Streptococcus thermophilus und Lactobacillus bulgaricum entstehenden Metaboliten zurückzuführen ist. Zwischen diesen biologisch aktiven Komponenten sind ausser Milchsäure auch freie Aminosäuren vorhanden, welche als wirksame Mittel in Cremen für die Hydratation, Nährung und Heilung der menschlichen Haut bekannt sind.Yoghurt is a variety of sour milk and is a product known for its nutritional and bioactive properties, which is due to its components formed during fermentation processes and metabolites formed as a result of the life activity of Streptococcus thermophilus and Lactobacillus bulgaricum. Among these biologically active components, apart from lactic acid, there are also free amino acids, which are known to be effective agents in creams for hydration, nourishment and healing of human skin. Bei der Milchfermentation aber, die nur unter der Wirkung der ihr eigenen Mikroflora erfolgt, werden unwesentliche Mengen an freien Aminosäuren erhalten (J. Schalitschev und Mitarbeiter, 8,1971, Heft 6). Die bekannten Hydroly-sate mit einem höheren Gehalt an Aminosäuren können aus Kasein erhalten werden.However, in milk fermentation, which takes place only under the action of its own microflora, insignificant amounts of free amino acids are obtained (J. Schalichev et al., 8, 1971, booklet 6). The known hydrolyzates with a higher content of amino acids can be obtained from casein. In der DDR-Patentschrift Nr. 11 959 wird ein für industrielle Schutzcremen benutztes Abbaumilcheiweiss erwähnt, zwar ohne jegliche Erklärung bis zu welchem Grade und in was für welche Produkte der Eiweissstoff zerlegt wird.In the GDR patent no. 11 959, a degradation milk protein used for industrial protective creams is mentioned, without any explanation to what extent and into what products the protein is broken down. Die tschechische Patentschrift Nr. 98 238 und eine ganze Reihe andere Patentschriften beschreiben Eiweisshydrolysa-te, aber von bis zu Aminosäuren zerlegtem Kasein. Die Ka-sein-Hydrolysate weisen zwar den Nachteil auf, dass sie von dem ganzen Bereich wertvoller Stoffe des Joghurts (Sauermilch) und von den sich durch die Lebensaktivität der Mikroorganismen Streptococcus thermophilus und Lactobacillus bulgaricum hervorgerufenen Fermentationsprozessen bildenden Metaboliten nichts erhalten.Czech Patent Specification No. 98 238 and a number of other patent specifications describe protein hydrolyzates, but of casein broken down into amino acids. Casein hydrolysates have the disadvantage that they do not contain the whole range of valuable substances in yoghurt (curdled milk) and the metabolites formed by the life activity of microorganisms Streptococcus thermophilus and Lactobacillus bulgaricum. Die Aufgabe der vorliegenden Erfindung ist es, ein lyophilisiertes, enzymatisch abgebautes Sauermilchprodukt, das für kosmetische und pharmazeutische Zwecke bestimmt ist, zur Verfügung zu stellen, wobei das erfindungsgemässe Sauermilchprodukt einen hohen Gehalt an freien Aminosäuren aufweist. Das erfindungsgemässe Produkt enthält alle in der Sauermilch bzw. im Joghurt vorhandenen Komponenten, die bei sich bei der Lebensaktivität der Sauermilch-Flora bildenden Metatabletten erhalten bleiben.The object of the present invention is to provide a lyophilized, enzymatically degraded sour milk product intended for cosmetic and pharmaceutical purposes, the sour milk product according to the invention having a high content of free amino acids. The product according to the invention contains all of the components present in sour milk or yoghurt that are retained in the metatablets formed during the life activity of the sour milk flora. Das erfindungsgemässe Sauermilchprodukt weist die folgende Zusammensetzung auf: 15,5 bis 16,5% freie Aminosäuren, 5 bis 11% Wasser, 45 bis 50% Laktose, 27 bis 33% gesamtes Eiweiss, 25 bis 28% lösliches Eiweiss, 1,4 bis 2% Peptonstickstoff, 7 bis 8% Asche, einen Säuregrad von 130° bis 150° TH, einen pH-Wert von 3,8 bis 4,1 und aktive Lactobacillus bulgaricum-Zellen von mehr als 100 000 pro g Sauermilchprodukt.The inventive sour milk product has the following composition: 15.5 to 16.5% free amino acids, 5 to 11% water, 45 to 50% lactose, 27 to 33% total protein, 25 to 28% soluble protein, 1.4 to 2% peptone nitrogen, 7 to 8% ash, an acidity of 130° to 150° TH, a pH of 3.8 to 4.1 and active Lactobacillus bulgaricum cells of more than 100,000 per g of sour milk product. Das erfindungsgemässe Sauermilchprodukt wird hergestellt, indem man entfettete, pasteurisierte und bis zu 45 °C abgekühlte Milch mit 0,1 bis 0,3% Pankreatin vermischt und nach 30 Minuten mit 1 bis 3% einer bakteriellen Kombination aus Streptococcus thermophilus Stamm 2 ST BTCC Nr.The sour milk product according to the invention is produced by mixing defatted, pasteurized milk that has been cooled down to 45 °C with 0.1 to 0.3% pancreatin and, after 30 minutes, adding 1 to 3% of a bacterial combination of Streptococcus thermophilus strain 2 ST BTCC No . 113 und Lactobacillus bulgaricum Stamm 5 SB BTCC Nr.113 and Lactobacillus bulgaricum strain 5 SB BTCC No. 114 beimpft wird, wonach sie drei Stunden lang bei 44-46 °C fermentiert wird, anschliessend 0,1 bis 0,3% Pepsin zugegeben werden, und man das so erhaltene Produkt bei 20-25 °C 24 Stunden lang aufbewahrt und danach lyophilisiert.114 is inoculated, after which it is fermented for 3 hours at 44-46°C, then 0.1-0.3% pepsin is added and the product thus obtained is kept at 20-25°C for 24 hours and then lyophilized . Die genannten Stämme wurden am 21. November 1977 unter dieser Bezeichnung im Staatlichen Institut für Heilmittel beim Ministerium für Gesundheitswesen, Boulevard Wladimir Zaimov Nr. 26, Sofia, Bulgarien, Bulgarian Type Culture Collection hinterlegt.Said strains were deposited under this designation on November 21, 1977 at the State Institute of Therapeutic Products at the Ministry of Health, Boulevard Vladimir Zaimov No. 26, Sofia, Bulgaria, Bulgarian Type Culture Collection. Die Erfindung wird anhand des nachstehend angeführten Beispiels näher erläutert.The invention is explained in more detail by means of the example given below. BeispielExample 100 kg entfettete Kuhmilch wird bei einer Temperatur von 95 °C während 30 Minuten pasteurisiert, und nachdem sie bis zu 45 °C abgekühlt ist, werden 0,15 kg Pankreatin zugegeben. Man lässt die Milch in diesem Zustand 30 Minuten lang stehen, wonach 2,5 kg Hefekultur aus einer bakteriellen Kombination von Streptococcus thermophilus Stamm 2 ST Nr. 113 und Lactobacillus bulgaricum Stamm 5 SB Nr. 114 beigefügt werden.100 kg of skimmed cow's milk is pasteurized at a temperature of 95 °C for 30 minutes, and after it has cooled to 45 °C, 0.15 kg of pancreatin is added. The milk is allowed to stand in this state for 30 minutes, after which 2.5 kg of yeast culture of a bacterial combination of Streptococcus thermophilus strain 2 ST No. 113 and Lactobacillus bulgaricum strain 5 SB No. 114 is added. Anschliessend wird die beimpfte Milch bei 45 °C drei Stunden lang bis zu einem Säuregrad von 75° TH und einem pH-Wert von 4 zur Fermentation gebracht, wonach 0,1 kg Pepsin zugegeben werden. Bis zur 24. Stunde wird der einen enzymatischen Eiweissabbau aufweisende Joghurt bei einer Zimmertemperatur von 20 °C aufbewahrt und danach lyophilisiert.The inoculated milk is then fermented at 45°C for 3 hours to an acidity of 75°TH and a pH of 4, after which 0.1 kg of pepsin is added. The yoghurt, which exhibits enzymatic protein degradation, is stored at a room temperature of 20° C. for up to the 24th hour and then lyophilized. Es werden 94,700 kg des fertigen lyophilisierten Produktes erhalten, welches ein weisses Pulver darstellt mit einem Gehalt an 16 g freien Aminosäuren pro 100 g trockene Substanz und 10 kg Wasser, 47 kg Laktose, 29,70 kg gesamtes Eiweiss, 27,15 kg lösliches Eiweiss, 1,9 kg Pepton-Stickstoff und 8% Asche. Der Säuregrad beträgt 147° TH, der pH-Wert 3,9, aktive Lactobacillus bulgaricum Zellen sind mehr als 100 000 pro g Sauermilchprodukt vorhanden und das Produkt weist die Antimikrobenwirkung: Staphylococcus aureaus (1:32) und Bacillus mesentericus (1:62) auf.94.700 kg of the finished lyophilized product are obtained, which is a white powder containing 16 g of free amino acids per 100 g of dry substance and 10 kg of water, 47 kg of lactose, 29.70 kg of total protein, 27.15 kg of soluble protein , 1.9 kg peptone nitrogen and 8% ash. Acidity is 147° TH, pH 3.9, active Lactobacillus bulgaricum cells are more than 100,000 per g of sour milk product and the product has antimicrobial activity: Staphylococcus aureus (1:32) and Bacillus mesentericus (1:62) on. Der Vorteil des auf diese Weise erhaltenen Produktes im Vergleich zu den bekannten Kasein-Lyophilisaten besteht im hohen Gehalt an freien Aminosäuren, in der Anwesenheit aller Komponenten des Joghurts bzw. der Sauermilch und der sich bei der Lebensaktivität des Streptococcus thermophilus und Lactobacillus bulgaricum bildenden Metaboliten. Wegen seines hohen Gehalts an biologisch aktiven freien Aminosäuren, welcher sowohl in Bulgarien als auch aus der entsprechenden Literatur nicht bekannt ist, samt den übrigen erhaltenen Stoffen der Milch und den Metaboliten eignet sich das erfindungsgemässe Produkt besonders gut für kosmetische und pharmazeutische Zwecke.The advantage of the product obtained in this way compared to the known casein lyophilisates is the high content of free amino acids, the presence of all components of yoghurt or sour milk and the metabolites formed during the life activity of Streptococcus thermophilus and Lactobacillus bulgaricum. Because of its high content of biologically active free amino acids, which is not known either in Bulgaria or in the relevant literature, together with the other substances obtained from the milk and the metabolites, the product according to the invention is particularly suitable for cosmetic and pharmaceutical purposes. 55 1010 1515 2020 2525 3030 3535 4040 4545 5050 5555 6060 6565 SS
CH12468/78A 1977-12-06 1978-12-06 Lyophilised, enzymatically degraded sour milk product CH647945A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG7737971A BG27574A1 (en) 1977-12-06 1977-12-06 Enzime opening up lyophilisate and method of its obtaining

Publications (1)

Publication Number Publication Date
CH647945A5 true CH647945A5 (en) 1985-02-28

Family

ID=3904028

Family Applications (1)

Application Number Title Priority Date Filing Date
CH12468/78A CH647945A5 (en) 1977-12-06 1978-12-06 Lyophilised, enzymatically degraded sour milk product

Country Status (7)

Country Link
AT (1) AT366912B (en)
BG (1) BG27574A1 (en)
CH (1) CH647945A5 (en)
DE (1) DE2852779A1 (en)
ES (1) ES475972A1 (en)
FR (1) FR2411001A1 (en)
SU (2) SU1256747A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3024318A1 (en) * 1980-06-27 1982-01-28 Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin COSMETIC AGENTS
JPS58198408A (en) * 1982-05-14 1983-11-18 Yakult Honsha Co Ltd Cosmetic
FR2598889B1 (en) * 1986-05-20 1990-12-21 Dietetique Cie Gle PROCESS FOR THE MANUFACTURE OF MILK YOGURT FERMENTATION PRODUCTS IN THE DRY CONDITION, AND PRODUCTS OBTAINED.
FR2696932B1 (en) * 1992-10-19 1994-11-25 Sederma Sa New compositions for cosmetic use consisting of the association of a fermentation filtrate and plant extracts.
JPH10502821A (en) * 1994-07-22 1998-03-17 ザ グッドライフ カンパニー アンド フレンズ プロプライエタリー リミテッド Starter culture vessel and method of using the same
US5656268A (en) * 1995-04-21 1997-08-12 Sorodsky; Michael Biological product
ES2157777B1 (en) * 1999-03-30 2002-03-01 Dermofarm S A COSMETIC CREAM
DE10325404B4 (en) * 2003-06-05 2013-05-29 Willy Thenn Aqueous suspension medium with viable lactic acid bacteria for probiotic applications
DE60335880D1 (en) 2003-12-05 2011-03-10 Kpss Kao Gmbh Hair conditioning and cleaning composition
EP1541116B1 (en) * 2003-12-05 2006-04-12 KPSS-Kao Professional Salon Services GmbH Hair styling composition
BG66485B1 (en) * 2006-10-09 2015-03-31 Мария БАЛТАДЖИЕВА Lactobacillus delbrueckii subsp. bulgaricus strain with a wide range of applications

Also Published As

Publication number Publication date
AT366912B (en) 1982-05-25
SU1256747A1 (en) 1986-09-15
ATA871278A (en) 1981-10-15
BG27574A1 (en) 1979-12-12
FR2411001A1 (en) 1979-07-06
FR2411001B3 (en) 1981-10-02
DE2852779A1 (en) 1979-06-13
SU1001938A1 (en) 1983-03-07
ES475972A1 (en) 1980-04-01

Similar Documents

Publication Publication Date Title
DE69737420T2 (en) MILK ALLOY THE SPECIAL STRAIN OF LACTOBACILLUS ACIDOPHILUS CONTAINS AND USES
DE602004005029T2 (en) PROBIOTIC COMPOSITION COMPRISING AT LEAST TWO MILK ACID BACTERIA INTENDED TO COLORIZE THE STOMACH'S DARM TRAIN, IN COMBINATION THUS CONTAINING THE PROPERTIES IN THE DARM TO BIND TO THE DARM, PROTECT AGAINST INFECTION, AND FERMENTATION OF FIBERS
EP0357162B1 (en) Process for modifying whey
CH647945A5 (en) Lyophilised, enzymatically degraded sour milk product
DE3841152A1 (en) USE OF BACTERIA-LYING ENZYME PRODUCT AS AN ADDITIVE TO IMPROVE THE FEED RECYCLING IN ANIMAL PRODUCTION
DE2134179A1 (en) Prepns contg several bifidobacterium species - for normalizing intestinal flora
DE60005104T2 (en) DIET ADDITIVE FROM FERMENTED MILK PRODUCTS FOR PREVENTING ÖSTEOPOROSIS
DE3120505C2 (en) Process for the production of solid sour milk products
DE3125797A1 (en) Dietetic agent
GB2037160A (en) Milk-derived products
EP1028977B1 (en) Bifidus stimulating peptides and their uses
DE19610672A1 (en) Frozen yogurt and process for making it
DE60124255T2 (en) USE OF EXOGENOUS MILKY ACID BACTERIA FOR THE TREATMENT OF DISEASES CAUSED BY ACTINOMYCES NAESLUNDII
DD222895A5 (en) PROCESS FOR PREPARING A HYPOTRIGLYCERIDEMICALLY ACTIVE POLYSACCHARIDE
DE1952361A1 (en) Yoghurt prodn with bifdus bacteria added - to souring bacteria
DE1019896B (en) Process for the production of milk products, such as sour milk or the like, with the addition of bacteria
WO1997009962A1 (en) Process for obtaining amino acids from proteins and use of the amino-acid-containing products obtained
DE1492779B2 (en) Process for the manufacture of sour milk products
DE3819012A1 (en) AGENTS FOR COMBATING CLOSTRIDIA
DE2249964C3 (en) Process for the production of an active ingredient from grain germs
DE3536342A1 (en) Medicine from milk, milk products and juices from fruit, fruit plants and vegetables containing lactic acid
DE2939528C2 (en)
DE3326347C2 (en) Process for producing drinking whey
DE2004406C3 (en) Process for the production of a rye active ingredient concentrate
DE718285C (en) Process for the production of a baking aid from milk

Legal Events

Date Code Title Description
PL Patent ceased